Forward Science donates OralID to NC Missions of Mercy

DrBicuspid.com staff writers
Jul 28, 2014

Forward Science Technologies, the developer of OralID and CytID, recently awarded an OralID device to North Carolina Missions of Mercy (NCMOM).

The company launched a "Like us on Facebook" charity campaign earlier this year encouraging dental professionals and their peers to help the company reach 500 "likes" on Facebook. The company promised that after the goal was reached, they would donate a device to a charitable organization.

"NCMOM does great things for the people of North Carolina, and we feel that adding OralID to their arsenal of tools allows them to continue their quest to serve those in need," explained Robert Whitman, CEO of Forward Science Technologies, in a release.

The company will continue the campaign, and for each additional 500 likes on Facebook, Forward Science will donate an OralID device to a deserving nonprofit organization.

To participate in the program or learn more about OralID, visit the OralID Facebook page. To nominate a nonprofit, please email [email protected] with your suggested organization and a brief description of its work.

Latest in Oral Cancer
Bill Brodie
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
April 18, 2024
Do you have patients who can’t or simply won’t floss?
Sponsored
Do you have patients who can’t or simply won’t floss?
February 2, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
New test may be better way to detect oral cancer
March 26, 2024
Cancer Cell
Oral cancer detection with a stroke of a brush?
January 30, 2024
Related Stories
2013 04 10 10 14 48 506 Cancer Cell 200
Oral Cancer
Antipain agent shrinks oral cancers without damaging healthy tissue
2013 04 10 10 14 48 506 Cancer Cell 200
Oral Cancer
Genetic testing may predict aggressiveness of oral cancer
2013 12 26 15 30 33 820 Cancer Thru Magnifying Glass 200
Oral Cancer
Salivary miRNA could provide noninvasive way to detect OSCC
Do you have patients who can’t or simply won’t floss?
Sponsor Content
Do you have patients who can’t or simply won’t floss?
More in Oral Cancer
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
By Kevin Henry
As Oral Cancer Awareness Month continues, we take a look at a company that is using biomarkers as a way to catch oral cancer earlier and give patients a better chance of survival.
April 18, 2024
Bill Brodie
Nanoparticles to be developed to treat oral cancer
By Ava Barros
A lipid nanoparticles platform may treat oral squamous cell carcinoma by changing the genetic material of lymph nodes, according to research presented at the International Association for Dental, Oral, and Craniofacial Research.
April 1, 2024
Researcher
New test may be better way to detect oral cancer
By Ava Barros
A new test may detect a germ-fighting protein associated with oral cancer, track precancerous lesions, and determine when a biopsy is necessary. The study was recently published in Cell Reports Medicine.
March 26, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
Oral cancer detection with a stroke of a brush?
By Ava Barros
Researchers at the University of Illinois at Chicago College of Dentistry have created a diagnostic test kit that detects oral cancer early with a brush biopsy that can be done in a dental office, according to an article published by the university.
January 30, 2024
Cancer Cell
It’s not cheesy. An antimicrobial may treat oral cancer.
By Ava Barros
Researchers are conducting a clinical trial to determine whether an antimicrobial food additive found in cheese may be used to treat oral cell carcinoma, according to the University of California, Los Angeles School of Dentistry.
January 29, 2024
Bacteria Microscope
This numbing agent may kill HNC cells
By Ava Barros
The common dental numbing agent lidocaine triggers specific bitter taste receptors in the mouth that may ultimately lead to the death of head and neck cancer cells, according to a preclinical study recently published in Cell Reports.
December 5, 2023
Anesthetic Needle Vials
Young users of e-cigarettes more likely to report chronic stress
By Amerigo Allegretto
Young people who vape are more than twice as likely to report experiencing chronic stress.
October 3, 2023
Vaping Teenager
'Gates of heaven' calcium channel may drive oral cancer growth, pain
By Will Morton
New York University researchers suggest that ORAI1 calcium channel activity in oral cancer cells could be targeted to reduce the growth of oral tumors and reduce pain, according to a study that was recently published in Science Signaling.
September 12, 2023
Cell Gene Therapy Dna
MUSC researchers developing oral cancer vaccine
By Amerigo Allegretto
Researchers from the Medical University of South Carolina (MUSC) are developing a new type of personalized vaccine to prevent recurrences of oral cancer.
September 7, 2023
Researcher
Researchers awarded grant to study radiation therapy delays
By Amerigo Allegretto
Researchers from South Carolina have been awarded a $3.5 million grant to reduce delays in radiation therapy for head and neck cancers.
August 28, 2023
Radiation Therapy
Raising awareness of oral cancer through patient communication
By Misty Mattingly, RDH
With increasing rates of oral cancer, it’s time to re-examine our approach to informing patients about the risks, writes Misty Mattingly, RDH.
August 24, 2023
Misty Mattingly, RDH.
High oral HPV burden puts older men at risk of oropharyngeal cancer
By Kate Madden Yee
Older men carry the highest burden of oral HPV, putting them at the greatest of oropharyngeal cancer.
August 22, 2023
Male Patient Dental Chair
Page 1 of 115
Next Page